Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-454P (RNA, U6 small nuclear 454, pseudogene) is a pseudogene corresponding to U6 small nuclear RNA (snRNA), a highly conserved non-coding RNA component involved in the splicing of precursor mRNA in eukaryotes. Numerous pseudogenes for U6 snRNA exist in the human genome, originating from retrotransposition events involving LINE-1 and other retroelements. These pseudogenes are usually non-functional, do not produce active snRNAs, and are generally not involved in canonical RNA splicing or any recognized biological process. There are occasional reports that some pseudogenes may exert regulatory effects at the DNA or RNA level, but there is no specific evidence of such a role for RNU6-454P. This locus is not considered a therapeutic target, nor is it known to interact with drugs, serve as a biomarker, or be involved in disease mechanisms. It is most accurately classified as a genomic pseudogene of a key RNA involved in splicing machinery, reflecting the dynamic history of retrotransposition and genomic evolution in mammals.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 454, pseudogene (RNU6-454P).